Related Experiment Video

Updated: Nov 7, 2025

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.1K

Correction to: Pitfalls of clinical exome and gene panel testing: alternative transcripts

Dale L Bodian1, Prachi Kothiyal2, Natalie S Hauser2

  • 1Inova Translational Medicine Institute, Inova Health System, Falls Church, VA, USA. dale.bodian@inova.org.

Genetics in Medicine : Official Journal of the American College of Medical Genetics
|May 4, 2021
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.6K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.3K

Related Experiment Videos

Last Updated: Nov 7, 2025

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.1K
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.6K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.3K

Related Concept Videos

RNA Splicing01:32

RNA Splicing

58.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
58.4K
Alternative RNA Splicing02:18

Alternative RNA Splicing

23.5K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
23.5K

Articles linked to this work by shared authors, journal, and citation graph.

Nonhuman Primate Genomes Have Limited Relevance for Evaluating Human CRISPR Off-Target Effects.

Human gene therapy·2026

Evidence for a transgenerational mutational signature from ionizing radiation exposure in humans.

Scientific reports·2025

Rare missense variants in FNDC1 are associated with severe adolescent idiopathic scoliosis.

Journal of medical genetics·2025

Base-editing corrects metabolic abnormalities in a humanized mouse model for glycogen storage disease type-Ia.

Nature communications·2024

Harmonizing heterogeneous transcriptomics datasets for machine learning-based analysis to identify spaceflown murine liver-specific changes.

NPJ microgravity·2024

MSL2 variants lead to a neurodevelopmental syndrome with lack of coordination, epilepsy, specific dysmorphisms, and a distinct episignature.

American journal of human genetics·2024

Disease characteristics of SEPSECS deficiency: an international, retrospective, multicenter cohort study.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Rapid Genome Sequencing Identifies Treatable Conditions in Non-Intensive Care Unit Hospitalized Children.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Transmission ratio distortion of NF1 mutant alleles in familial Neurofibromatosis type 1.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

The Patient-reported Genetic testing Utility InDEx (P-GUIDE): A novel measure of personal utility.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Retrospective Study of Foramen Magnum Development in Patients with Achondroplasia Starting Vosoritide Before Age Three.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Familial Risk Stratification Across Cancer Syndromes Using Fam3PRO.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

New-Onset Raynaud Phenomenon during Ropeginterferon Alfa-2b Therapy for Polycythemia Vera: A Case Report and Review of the Literature.

Case reports in oncology·2026

131I-labeled engineered hybrid cell membrane biomimetic nanocarrier targets gastric cancer and enhances radioimmunotherapy.

Materials today. Bio·2026

Plant-Derived Extracellular Vesicles Delivered by Microinfusion Microneedling for Androgenetic Alopecia: A Retrospective Case Series.

Skin appendage disorders·2026

Erratum: Brem EA, Shieh K, Juarez D, et al. A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy. Blood Neoplasia. 2024;1(4):100036.

Blood neoplasia·2026

Machine learning driven precision medicine in tacrolimus dosing: current research and future perspectives in liver and kidney transplantation.

Frontiers in immunology·2026

Modular engineered outer membrane vesicles for synergistic cancer immunotherapy via PD-L1 blockade and epigenetic reprogramming.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us